Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Regulation and Compliance > Federal Regulation > FINRA

FINRA Sweeps BDs for Info on VIX-Linked Products

By Emily Zulz

X
Your article was successfully shared with the contacts you provided.

The Financial Industry Regulatory Authority said it is conducting a targeted review of products linked to the Chicago Board Options Exchange Volatility Index (VIX).

FINRA posted an exam letter saying that its review will focus on the supervisory processes followed by the firm to identify and mitigate sales practice risks associated with recommendations to non-institutional purchasers of VIX-linked products. This includes, but is not limited to, unsuitable recommendations, misrepresentations and appropriateness of any required disclosures to customers.

FINRA will also assess the firm’s supervisory controls with respect to product vetting, testing, and approval in this space.

FINRA asks that firms provide documents and information applicable to the period October 1, 2017, through February 28, 2018, by no later than April 20, 2018.

For example, firms will need to provide written supervisory procedures, compliance manuals, training materials, and any other written guidance given to its registered persons regarding the solicitation, recommendation, and supervision of VIX-linked products.

They’ll also need to provide an electronic copy of all VIX-linked securities transactions effected within accounts of non-institutional customers during the review period.

In addition to other information, firms will also have to produce copies of any customer complaints concerning VIX-linked products.

FINRA and other regulators conduct targeted exams, known as sweeps, to gather information and carry out investigations. Sweep information is used to focus examinations and pinpoint regulatory response to emerging issues.

— Related on ThinkAdvisor:

Emily Zulz

@think_emilyz

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.